3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Pancreatic Neoplasms
1
Neoplasms, Glandular and Epithelial
1
Neoplasms by Histologic Type
1
Leukemia, Myeloid, Acute
1
Carcinoma
1
BRAF V600E Mutation
1
Adenocarcinoma
1
Interventions
Cisplatin
3
anlotinib
2
Sunitinib
2
Radiotherapy, Intensity-Modulated
2
Gemcitabine
2
Carboplatin
2
olaparib
1
niraparib
1
ixabepilone
1
Taxes
1
Sorafenib
1
Radiofrequency Ablation
1
Paclitaxel
1
Nimorazole
1
Irinotecan
1
Filgrastim
1
Endoscopic Mucosal Resection
1
Cobicistat
1
Chemoradiotherapy
1
Capecitabine
1
CP protocol
1
Bevacizumab
1
Albumin-Bound Paclitaxel
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Neoplasms, Glandular and Epithelial
×
Cobicistat
×
Clear all
NCT05494866
2025-03-25
IntenSify
German Cancer Research Center
Phase 1
Terminated
6 enrolled